PND74 How Have Manufacturers Overturned Negative Reimbursement Decisions? A Case Study Using Natalizumab for Multiple Sclerosis
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.1998
https://www.valueinhealthjournal.com/article/S1098-3015(12)03711-4/fulltext
Section Title :
Neurological Disorders
Section Order :
1486
First Page :
A559
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03711-4&doi=10.1016/j.jval.2012.08.1998